The objective of this study was to assess the relationship between the severity of proteinuria identified by a spot simple urine dipstick test (UD), spot urine albumin to creatinine ratio dipstick (UACRD) test, spot urine microalbumin to creatinine ratio (UACR) test, spot urine total protein to creatinine ratio (UPCR) test, and 24-h urine total protein (TP) content in gynecologic cancer patients receiving bevacizumab. This evidence concerns the gene ALB and female reproductive organ cancer.